Semiramis L. Carbajal-Mamani

Semiramis L. Carbajal-Mamani

Auto-generated profile, based on publicly available information

Semiramis L. Carbajal-Mamani

Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
SCSemiramis L. Carbajal-Mamani
Semiramis L. Carbajal-Mamani
BDBahram Dideban
Bahram Dideban
DSDavid Schweer
David Schweer
KBKristi T. Balavage
Kristi T. Balavage
LCLinus Chuang
Linus Chuang
JCJoel Cardenas-Goicoechea
Joel Cardenas-Goicoechea

15 February 2022 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
MSMassoud Shoraka
Massoud Shoraka
SWShu Wang
Shu Wang
SCSemiramis L. Carbajal-Mamani
Semiramis L. Carbajal-Mamani
HHHaoting Han
Haoting Han
BABernie Amaro
Bernie Amaro
JCJoel Cardenas-Goicoechea
Joel Cardenas-Goicoechea
Data are limited in the management of elderly women with endometrial cancer as they are under-represented in clinical trials. The aim of this study was to evaluate the outcomes of women ≥70 years who underwent hysterectomy. One hundred and twenty-one patients met the inclusion criteria. The median age among the cohort was 75 years (range: 70–91), and 52% underwent robotic surgery. The five-year overall survival (OS) rate was 67%. The five-year cumulative incidence of recurrence was 19%. Based on univariate analysis, white race, lower ASA score, higher pre-operative and post-operative haematocrit, lower estimated blood loss, stage I and robotic surgery were associated with improved OS. On multivariable analysis, ASA score, preoperative haematocrit, estimated blood loss and stage were associated with survival. Survival rates among older women were low and disease recurrence was high. Robotic surgery was safe and appeared to improve perioperative outcomes in older women with endometrial cancer.